Table 5.
Disorder | Phenotypes | Culture methods | Potential applications | Reference |
---|---|---|---|---|
Amyotrophic lateral sclerosis (ALS) | Down regulation of VAPB expression, failure of motor neurons | By either direct reprogramming or iPSC-derived NPCs | Generated functional astroglia from human induced pluripotent stem cells (iPSCs) carrying an ALS-causing TDP-43 mutation | Serio et al., 2013 |
Human iPSC-derived astrocytes showed an increase in Cx43 protein, | Almad et al., 2016 | |||
Rett syndrome (RTT) | Fewer synapses, reduced dendritic spine density, and soma size | iPSC-derived NPCs | –RTT-iPSCs showed the recapitulation of RTT phenotypes. –MeCP2 seems to have an essential function in astrocytes | Dajani et al., 2013 |
Alzheimer disease (AD) | Intracellular accumulation of Aβ, increased ROS production, ER stress | Embryoid body formation by dual smad molecules | Kondo et al., 2013 | |
Huntington disorder | Trinucleotide repeat expansion (CAG) in exon 1 of huntington (HTT) | iPSC-derived NPCs | –Generated adult form of HD (F-HD-iPSCs). –Identified a cellular vacuolation phenotype similar to HD patients. | Juopperi et al., 2012 |